Retour
Fourchette du Jour
28,99 €
30,65 €
Fourchette 52 Semaines
14,06 €
42,00 €
Volume
632 741
Moyenne 50J / 200J
32,70 €
/
29,92 €
Clôture Précédente
30,01 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -17,0 | 0,3 |
| P/B | 5,1 | 2,9 |
| ROE % | -28,3 | 3,7 |
| Net Margin % | -905,7 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
47,20 €
+57.0%
Low: 37,00 €
High: 55,00 €
BPA Prévisionnel
-1,91 €
CA Est.
28 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
3,66 €
-0,01 € – 13,82 €
|
1,3 B | 6 |
| FY2029 |
1,59 €
0,00 € – 6,00 €
|
830 M | 6 |
| FY2028 |
-0,21 €
-0,81 € – 0,00 €
|
430 M | 7 |
Points Clés
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -148,03M
PEG of 0,62 suggests growth is underpriced
Capital efficient — spends only 1,09% of revenue on capex
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)-50,61%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-28,29%
ROIC-24,76%
Net Margin-905,74%
Op. Margin-1002,90%
Sécurité
Debt / Equity
0,00
Current Ratio7,88
Interest Coverage0,00
Valorisation
P/E Ratio
-16,96
P/B Ratio5,06
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -50,61% | Revenue Growth (3Y) | 26,38% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 22,50M | Net Income (TTM) | -203,82M |
| ROE | -28,29% | ROA | -26,49% |
| Gross Margin | 99,74% | Operating Margin | -1002,90% |
| Net Margin | -905,74% | Free Cash Flow (TTM) | -148,03M |
| ROIC | -24,76% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 7,88 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -16,96 | P/B Ratio | 5,06 |
| P/S Ratio | 153,59 | PEG Ratio | 0,62 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 3,46B | Enterprise Value | 2,97B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 22,50M | 45,56M | 14,09M | 102,69M | 0,0 |
| Net Income | -203,82M | -241,60M | -176,94M | -22,63M | -41,79M |
| EPS (Diluted) | -1,75 | -2,56 | -2,15 | -1,19 | -3,34 |
| Gross Profit | 22,44M | 45,56M | 14,09M | 102,69M | 0,0 |
| Operating Income | -225,68M | -176,29M | -182,97M | -3,56M | -34,98M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 769,28M | 864,62M | 347,10M | 478,50M | 67,99M |
| Total Liabilities | 85,85M | 107,12M | 58,70M | 48,43M | 11,36M |
| Shareholders' Equity | 683,43M | 757,50M | 288,39M | 430,07M | 56,63M |
| Total Debt | 202 000,0 | 448 000,0 | 60 000,0 | 126 000,0 | 186 511,0 |
| Cash & Equivalents | 490,00M | 771,74M | 340,45M | 467,73M | 60,38M |
| Current Assets | 675,70M | 863,41M | 346,79M | 477,98M | 66,96M |
| Current Liabilities | 85,79M | 106,92M | 49,90M | 36,06M | 11,24M |